» Articles » PMID: 12642601

Regulation and Function of the Interleukin 13 Receptor Alpha 2 During a T Helper Cell Type 2-dominant Immune Response

Overview
Journal J Exp Med
Date 2003 Mar 19
PMID 12642601
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Highly polarized type 2 cytokine responses can be harmful and even lethal to the host if they are too vigorous or persist too long. Therefore, it is important to elucidate the mechanisms that down-regulate these reactions. Interleukin (IL)-13 has emerged as a central mediator of T helper cell (Th)2-dominant immune responses, exhibiting a diverse array of functional activities including regulation of airway hyperreactivity, resistance to nematode parasites, and tissue remodeling and fibrosis. Here, we show that IL-13 receptor (R)alpha2 is a critical down-regulatory factor of IL-13-mediated tissue fibrosis induced by the parasitic helminth Schistosoma mansoni. IL-13Ralpha2 expression was induced after the onset of the fibrotic response, IL-10, IL-13, and Stat6 dependent, and inhibited by the Th1-inducing adjuvant IL-12. Strikingly, schistosome-infected C57BL/6 and BALB/c IL-13Ralpha2-deficient mice showed a marked exacerbation in hepatic fibrosis, despite displaying no change in granuloma size, tissue eosinophilia, or mastocytosis. Fibrosis increased despite the fact that IL-13 levels decreased significantly in the liver and serum. Importantly, pathology was prevented when IL-13Ralpha2-deficient mice were treated with a soluble IL-13Ralpha2-Fc construct, formally demonstrating that their exacerbated fibrotic response was due to heightened IL-13 activity. Together, these studies illustrate the central role played by the IL-13Ralpha2 in the down-regulation of a chronic and pathogenic Th2-mediated immune response.

Citing Articles

Intranasal dupilumab improves responsiveness to steroid in an asthma mouse model.

Khalid Salah Al-Sheakly B, Saheb Sharif-Askari F, Sharif-Askari N, Zakri A, Mdkhana B, Wed Abdelaziz Eladham M Inflamm Res. 2025; 74(1):43.

PMID: 39969581 DOI: 10.1007/s00011-024-01991-5.


A Comprehensive Review of Biologics in Phase III and IV Clinical Trials for Atopic Dermatitis.

Waligora-Dziwak K, Danczak-Pazdrowska A, Jenerowicz D J Clin Med. 2024; 13(14).

PMID: 39064040 PMC: 11277805. DOI: 10.3390/jcm13144001.


Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo.

Leland P, Degheidy H, Lea A, Bauer S, Puri R, Joshi B Clin Transl Med. 2024; 14(5):e1664.

PMID: 38685487 PMC: 11058282. DOI: 10.1002/ctm2.1664.


Potential Indications of Dupilumab in Th-2 Inflammatory Disease.

Ilaria P, Nevena S, Ersilia T, Nicoletta B, Federica T, Di Fraia M Rev Recent Clin Trials. 2023; 19(1):53-61.

PMID: 38141197 DOI: 10.2174/0115748871263396231121060901.


Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis.

Gumkowska-Sroka O, Kotyla K, Mojs E, Palka K, Kotyla P Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37630981 PMC: 10458905. DOI: 10.3390/ph16081066.


References
1.
Hilton D, Zhang J, Metcalf D, Alexander W, Nicola N, Willson T . Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A. 1996; 93(1):497-501. PMC: 40265. DOI: 10.1073/pnas.93.1.497. View

2.
Kaplan M, Schindler U, Smiley S, Grusby M . Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 1996; 4(3):313-9. DOI: 10.1016/s1074-7613(00)80439-2. View

3.
Caput D, Laurent P, Kaghad M, Lelias J, Lefort S, Vita N . Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem. 1996; 271(28):16921-6. DOI: 10.1074/jbc.271.28.16921. View

4.
Gazzinelli R, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kuhn R . In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol. 1996; 157(2):798-805. View

5.
Pearce E, Cheever A, Leonard S, Covalesky M, Fernandez-Botran R, Kohler G . Schistosoma mansoni in IL-4-deficient mice. Int Immunol. 1996; 8(4):435-44. DOI: 10.1093/intimm/8.4.435. View